Cactus Life Sciences Top 5 Trends of 2024

Cactus Life Sciences’ Top 5 Trends of 2024: Insights Driving Tomorrow’s MedComms

Here, we revisit our most thought-provoking articles and whitepapers, each addressing pivotal trends that influence the ever-evolving biopharma landscape...
Read More

Top Stories

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...
Involve Medical Affairs in insight management, early phases of clinical trials, etc.

It’s Never Too Soon: How and When to

Engagement with Medical Affairs is critical at every...
Leverage Social Media to Transform Medical Affairs | Promoting Disease Awareness, Ensuring Compliance and Assessing Outcomes

Leveraging Social Media to Transform Medical

This whitepaper explores the role of social media in...
Fireside chat preview: Strategy and leadership in MedTech

Fireside Chat Preview: Strategy and Leadership in MedTech

Catch a sneak peek of an engaging fireside chat between Cactus Life Sciences and MedTech...
Trends in publication review of articles

Review Article Publication Trends

This poster was presented by representatives from Cactus Life Sciences at the 11th Annual Meeting...
EU MDR Whitepaper

EU MDR: Increasing Expectations for Clinical Evidence

While the global medical devices industry is closely watching how the European Union (EU) Medical...
A fireside chat on how MedTech leaders are called to respond to EU-MDR

Fireside Chat Part 1: How MedTech Leaders Are Called to Respond to EU MDR

A fireside chat on how MedTech leaders are called to respond to EU-MDR...
International publication guidelines in Asia

Awareness of International Publication Guidelines in Asia

This poster presents the results of an analysis of how familiar Asian authors are with...
FDA social media usage guidelines

US FDA (Food And Drug Administration) Social Medial Usage Guidelines: Compliance for Pharma Companies

This poster presents results of an analysis of trends in adherence of pharmaceutical companies to...

Learn more ABOUT our company.